ArticlePediatric cardiology2026
Hepatic Venous Flow for Assessing Liver Condition and Splanchnic Perfusion in Pediatric Congenital Heart Disease.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital heart disease (CHD) often requires intracardiac repair (ICR); however, its effects on splanchnic perfusion (SP) remain unclear. Currently, no available method can effectively assess liver status in children with CHD. In this study, the relationships among hepatic venous flow (HVF), SP, and liver status were examined in pediatric patients undergoing ICR. A total of 38 patients with CHD undergoing ICR were evaluated. HVF and stroke volume were measured using ultrasonography. HVF was divided into antegrade HVF (HVFant) and retrograde HVF (HVFret) components. Effective HVF (HVFeff) was defined as the absolute value of the net flow obtained by subtracting HVFret from HVFant. Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were measured preoperatively and postoperatively. After ICR, HVFant did not change, whereas HVFret substantially decreased and HVFeff increased. In addition, the AST and ALT levels decreased postoperatively. Preoperative ALT levels were negatively correlated with HVFant and HVFeff. ICR increased HVFeff and decreased AST and ALT levels, which may reflect improved SP and liver function in patients with CHD. HVF measurement may serve as a noninvasive tool for monitoring liver function and evaluating the effects of ICR.
Indexed as
Identifiers
42821080What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.